Símbolo de cotizaciónIBB
Clase de activoEquity
Gestor del fondoiShares
DomicilioUS
Ratio de gastos0.44%
Fundada en2001-02-05
Índice de referenciaNYSE Biotechnology (TR)
IBB was created on 2001-02-05 by iShares. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 10376.52m in AUM and 238 holdings. IBB tracks the performance of a modified market-cap-weighted index of US biotechnology companies listed on US exchanges.